Literature DB >> 6425297

The NADPH oxidase of human polymorphonuclear leukocytes. Evidence for regulation by multiple signals.

L C McPhail, C C Clayton, R Snyderman.   

Abstract

Activation of the membrane-bound NADPH oxidase in human polymorphonuclear leukocytes can be triggered by chemoattractants, the tumor promoter phorbol myristate acetate or the calcium ionophore A23187. We have shown previously that these stimuli have markedly different temporal patterns of oxidase activation (McPhail, L. C., and Snyderman, R. (1983) J. Clin. Invest. 72, 192-200), suggesting that each follows, at least in part, a unique transductional pathway. We now report that if leukocytes were sequentially exposed to any of several combinations of heterologous stimuli, the pattern of activation by the second stimulus was strikingly altered, resulting in a more rapid rate and enhanced level of oxidase activation by the second stimulus. This suggests that exposure of cells to the first stimulus (priming) had influenced an intermediate also used by the second stimulus. The signal for priming could be clearly distinguished from the signal causing oxidase activation by the dose-response curves for each, as well as by the use of several pharmacologic agents. In addition, if leukocytes were given sequential doses of homologous stimuli, either partial (phorbol myristate acetate) or full (N-formyl-methionyl-leucyl -phenylalanine and A23187) desensitization of oxidase activation was observed. These results demonstrate that these stimuli share a common intermediate in the pathway of oxidase activation. Moreover, the data indicate that NADPH oxidase activation is regulated by at least three distinct signals: signal 1 (priming), signal 2 (activation), and signal 3 (inactivation). It is likely that more than one intracellular messenger exerts a modulating influence on NADPH oxidase activity and that its regulation involves the interplay between several cellular control proteins.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6425297

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Recombinant human tumour necrosis factor (rTNF)2 enhances leukotriene biosynthesis in neutrophils and eosinophils stimulated with the Ca2+ ionophore A23187.

Authors:  R Roubin; P P Elsas; W Fiers; A J Dessein
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

2.  Differential control of azurophilic and specific granule exocytosis in Sendai-virus-permeabilized rabbit neutrophils.

Authors:  M M Barrowman; S Cockcroft; B D Gomperts
Journal:  J Physiol       Date:  1987-02       Impact factor: 5.182

3.  Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease.

Authors:  R A Ezekowitz; S H Orkin; P E Newburger
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

4.  Differential inhibition and potentiation of chemoattractant-induced superoxide formation in human neutrophils by the cell-permeant analogue of cyclic GMP, N2,2'-O-dibutyryl guanosine 3':5'-cyclic monophosphate.

Authors:  J Ervens; G Schultz; R Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-04       Impact factor: 3.000

Review 5.  NOX enzymes and Toll-like receptor signaling.

Authors:  Eric Ogier-Denis; Sanae Ben Mkaddem; Alain Vandewalle
Journal:  Semin Immunopathol       Date:  2008-05-21       Impact factor: 9.623

6.  Priming of human neutrophils by tumour necrosis factor-alpha and substance P is associated with tyrosine phosphorylation.

Authors:  D Lloyds; N P Brindle; M B Hallett
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

Review 7.  Protein phosphorylation associated with the stimulation of neutrophils. Modulation of superoxide production by protein kinase C and calcium.

Authors:  P G Heyworth; J A Badwey
Journal:  J Bioenerg Biomembr       Date:  1990-02       Impact factor: 2.945

8.  Identification and characterization of a monocyte-derived neutrophil-activating factor in corticosteroid-resistant bronchial asthma.

Authors:  J R Wilkinson; A E Crea; T J Clark; T H Lee
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

9.  Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase.

Authors:  C C Silliman; K L Clay; G W Thurman; C A Johnson; D R Ambruso
Journal:  J Lab Clin Med       Date:  1994-11

10.  Calcium mobilization and Rac1 activation are required for VCAM-1 (vascular cell adhesion molecule-1) stimulation of NADPH oxidase activity.

Authors:  Joan M Cook-Mills; Jacob D Johnson; Tracy L Deem; Atsuo Ochi; Lei Wang; Yi Zheng
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.